期刊
CARDIOVASCULAR DIABETOLOGY
卷 20, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12933-021-01356-w
关键词
Autonomic nervous system; Hypertension; Obesity; Type 2 diabetes; Selective imidazoline receptor agonists
资金
- Abbott
The incidence and prevalence of hypertension is increasing worldwide, often associated with other diseases such as diabetes mellitus, chronic kidney disease, dyslipidemia/hypercholesterolemia, and obesity. The autonomic nervous system, specifically the sympathetic nervous system (SNS), has been implicated in the pathophysiology of hypertension, and current antihypertensive management strategies, including pharmacotherapies targeting the SNS, are examined in this review with a focus on imidazoline receptor agonists.
The incidence and prevalence of hypertension is increasing worldwide, with approximately 1.13 billion of people currently affected by the disease, often in association with other diseases such as diabetes mellitus, chronic kidney disease, dyslipidemia/hypercholesterolemia, and obesity. The autonomic nervous system has been implicated in the pathophysiology of hypertension, and treatments targeting the sympathetic nervous system (SNS), a key component of the autonomic nervous system, have been developed; however, current recommendations provide little guidance on their use. This review discusses the etiology of hypertension, and more specifically the role of the SNS in the pathophysiology of hypertension and its associated disorders. In addition, the effects of current antihypertensive management strategies, including pharmacotherapies, on the SNS are examined, with a focus on imidazoline receptor agonists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据